EUVIMEDDescoperă EUVIMED
EditorialOpen access

Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply

Elyke H Visser iD, Martijn A Oude Voshaar, Reinier C A van Linschoten, Alexander G L Bodelier, Claire Fitzpatrick, Vincent de Jonge, Hestia Vermeulen, K Evelyne Verweij, Sanne van der Wiel, Daniëlle van der Horst, C Janneke van der Woude, Rachel L West and 1 more

Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 398-399

DOI: 10.1111/apt.70780 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-06-10. Written by Elyke H Visser and 12 co-authors. Institution: Department of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, the Netherlands. 7 references. The full text is freely available in PubMed Central. Funded by: AbbVie, Celltrion, Dr. Falk Pharma.

RezumatDate bibliograficeCiteRelated studies

Abstract (original language)

Niciun rezumat disponibil.

Authors and institutions

  • Department of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, the Netherlands.
  • Department of Gastroenterology & Hepatology, Erasmus MC, Rotterdam, the Netherlands.
  • Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.
  • Department of General Practice, Erasmus MC, Rotterdam, the Netherlands.
  • Department of Gastroenterology & Hepatology, Amphia Hospital, Breda, the Netherlands.
  • Department of Gastroenterology & Hepatology, IJsselland Hospital, Capelle aan de IJssel, the Netherlands.

ORCID profiles: Elyke H Visser

Funding

  • AbbVie
  • Celltrion
  • Dr. Falk Pharma
  • Ferring
  • Galápagos
  • Janssen Pharmaceuticals
  • Eli Lilly and Company
  • Pfizer

Cite

APA

Visser, E. H., Voshaar, M. A. O., van Linschoten, R. C. A., Bodelier, A. G. L., Fitzpatrick, C., de Jonge, V., Vermeulen, H., Verweij, K. E., van der Wiel, S., van der Horst, D., van der Woude, C. J., West, R. L., & van Noord, D. (2026). Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(3), 398-399. https://doi.org/10.1111/apt.70780

Vancouver

Visser EH, Voshaar MAO, van Linschoten RCA, Bodelier AGL, Fitzpatrick C, de Jonge V, et al. Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(3):398-399. doi:10.1111/apt.70780

BibTeX
@article{Visser2026,
  author = {Visser, Elyke H and Voshaar, Martijn A Oude and van Linschoten, Reinier C A and Bodelier, Alexander G L and Fitzpatrick, Claire and de Jonge, Vincent and Vermeulen, Hestia and Verweij, K Evelyne and van der Wiel, Sanne and van der Horst, Daniëlle and van der Woude, C Janneke and West, Rachel L and van Noord, Desiree},
  title = {Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {3},
  pages = {398--399},
  doi = {10.1111/apt.70780}
}
Start for free →